ES2103827T3 - Vacuna muerta inactivada del mycoplasma hyopneumoniae y metodo de empleo de la misma. - Google Patents

Vacuna muerta inactivada del mycoplasma hyopneumoniae y metodo de empleo de la misma.

Info

Publication number
ES2103827T3
ES2103827T3 ES91915945T ES91915945T ES2103827T3 ES 2103827 T3 ES2103827 T3 ES 2103827T3 ES 91915945 T ES91915945 T ES 91915945T ES 91915945 T ES91915945 T ES 91915945T ES 2103827 T3 ES2103827 T3 ES 2103827T3
Authority
ES
Spain
Prior art keywords
mycoplasma hyopneumoniae
provides
swine
same
bacterin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91915945T
Other languages
English (en)
Inventor
Gary R Petersen
Krishnaswamy Iyengar Dayalu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2103827T3 publication Critical patent/ES2103827T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION SUMINISTRA UNA BACTERIA QUE COMPRENDE UN MATERIAL AISLADO DE "MYCOPLASMA HYOPNEUMONIAE" VIRULENTO, INACTIVADO CON ETILENEIMIDO BINARIO, EN UNA CANTIDAD EFECTIVA PARA INMUNIZAR A UN CERDO CONTRA LA INFECCION POR "MYCOPLASMA HYOPNEUMONIAE" Y UN PORTADOR FISIOLOGICAMENTE ACPTABLE ADECUADO. LA INVENCION TAMBIEN SUMINISTRA UN METODO PARA PRODUCIR ESTA BACTERIA. LA INVENCION ADEMAS SUMINISTRA UN METODO PARA INACTIVAR UNA RAMA VIRULENTA DE "MYCOPLASMA HYOPNEUMONIAE" PONIENDO EN CONTACTO EL "MYCROPLASMA HYOPNEUMONIAE" CON ETILENEIMIDO BINARIO. FINALMENTE LA INVENCION TAMBIEN SUMINISTRA UN METODO PARA INMUNIZAR A LOS CERDOS CONTRA LA INFECCION POR "MYCOPLASMA HYOPNEUMONIAE" QUE COMPRENDE LA ADMINISTRACION A LOS CERDOS DE UNA DOSIS DEL MATERIAL SUFICIENTE PARA SU INMUNIZACION.
ES91915945T 1990-08-16 1991-08-16 Vacuna muerta inactivada del mycoplasma hyopneumoniae y metodo de empleo de la misma. Expired - Lifetime ES2103827T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/568,427 US5565205A (en) 1990-08-16 1990-08-16 Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof

Publications (1)

Publication Number Publication Date
ES2103827T3 true ES2103827T3 (es) 1997-10-01

Family

ID=24271248

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91915945T Expired - Lifetime ES2103827T3 (es) 1990-08-16 1991-08-16 Vacuna muerta inactivada del mycoplasma hyopneumoniae y metodo de empleo de la misma.

Country Status (13)

Country Link
US (1) US5565205A (es)
EP (1) EP0550477B1 (es)
JP (1) JP3040467B2 (es)
KR (1) KR100286573B1 (es)
AT (1) ATE151990T1 (es)
AU (1) AU643829B2 (es)
BR (1) BR9106748A (es)
CA (1) CA2089552C (es)
DE (1) DE69125842T2 (es)
DK (1) DK0550477T3 (es)
ES (1) ES2103827T3 (es)
GR (1) GR3024214T3 (es)
WO (1) WO1992003157A1 (es)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113916A (en) * 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
GB9108682D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Production of vaccines
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
FR2696186B1 (fr) * 1992-09-28 1994-12-02 Pasteur Institut Souches de Mycoplasma. fermentans cytopathogène et procédés de diagnostic in vitro et d'immunisation mettant en Óoeuvre de telles souches.
EP0839050B1 (en) * 1992-09-28 2004-08-11 Wyeth Holdings Corporation Method of enhancing cell mediated immune responses
US5604096A (en) * 1993-03-04 1997-02-18 Schaeffer; Warren I. Fluorometric quantitation of mycoplasmas
US5788962A (en) * 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
US6114108A (en) * 1995-08-29 2000-09-05 V.I. Technologies, Inc. Methods and compositions for the selective modification of viral nucleic acids
US6136586A (en) * 1995-08-29 2000-10-24 Vi Technologies, Inc. Methods for the selective modification of viral nucleic acids
US5891705A (en) * 1997-04-08 1999-04-06 Pentose Pharmaceuticals, Inc. Method for inactivating a virus
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6352695B1 (en) 1997-10-03 2002-03-05 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
US6093564A (en) * 1997-10-03 2000-07-25 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
AU1535299A (en) * 1997-11-26 1999-06-15 Iowa State University Research Foundation Inc. Recombinant (mycoplasma hyopneumoniae) vaccine
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US6369048B1 (en) 1998-01-12 2002-04-09 V.I. Technologies, Inc. Methods and compositions for inactivating viruses
US6403359B1 (en) 1998-09-25 2002-06-11 V. I. TECHNOLOGIES, Inc. Solid phase quenching systems
US6617100B2 (en) 1998-09-25 2003-09-09 V.I. Technologies, Inc. Solid phase quenching systems
BR0015398A (pt) * 1999-11-08 2002-06-25 Biomune Vacinas para mycoplasma bovis e processos de uso
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
EP2027873B8 (en) 2001-07-02 2015-11-11 Zoetis Services LLC One dose vaccination with mycoplasma hyopneumoniae
CN1612749A (zh) 2001-07-02 2005-05-04 辉瑞产品公司 用于减弱牲畜体内牛支原体肺炎的猪肺炎支原体疫苗和方法
US20030147914A1 (en) * 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
GB0507632D0 (en) * 2005-04-15 2005-05-25 Secr Defence Vaccine
GB0519871D0 (en) 2005-09-30 2005-11-09 Secr Defence Immunogenic agents
DK3766518T3 (da) * 2005-12-29 2026-04-13 Boehringer Ingelheim Animal Health Usa Inc Immunogen pcv2-sammensætning til mindskelse af kliniske symptomer hos grise
EP3868400A1 (en) 2005-12-29 2021-08-25 Boehringer Ingelheim Animal Health USA Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
EP2859900A1 (en) * 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
PT2094872T (pt) * 2006-12-15 2017-04-27 Boehringer Ingelheim Vetmedica Inc Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US20090017064A1 (en) * 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
EP2217271B1 (en) 2007-11-06 2016-05-04 Zoetis Services LLC Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine
CN101932336B (zh) * 2007-12-31 2014-07-09 贝林格尔.英格海姆维特梅迪卡有限公司 有外来氨基酸插入的pcv2 orf2病毒样颗粒
KR20100113582A (ko) 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
US8444989B1 (en) 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
GB0900455D0 (en) 2009-01-13 2009-02-11 Secr Defence Vaccine
TWI627281B (zh) * 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
CN103182076B (zh) * 2011-12-29 2015-06-17 北京大北农科技集团股份有限公司 一种猪支原体肺炎灭活疫苗及其制备方法
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
HUE059179T2 (hu) 2012-09-10 2022-10-28 Galenbio Inc Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
CN105579060B (zh) 2013-09-25 2021-03-16 硕腾服务有限责任公司 Pcv2b趋异株疫苗组合物以及使用方法
MX373884B (es) 2013-10-02 2020-03-26 Boehringer Ingelheim Animal Health Usa Inc Variante de la proteína pcv2 orf2 y partículas similares al virus compuestas por ésta.
CN103585622B (zh) * 2013-11-25 2015-09-02 江苏省农业科学院 猪支原体肺炎疫苗株的应用
EP3498847A4 (en) 2016-08-12 2020-03-04 Innovac VACCINE COMPOSITION FOR PREVENTING PORCINE MYCOPLASMA INFECTIONS WITH RECOMBINANT PROTEIN
JP7510874B2 (ja) * 2017-12-22 2024-07-04 ヒプラ シエンティフィック エセ．エレ．ウ． マイコプラズマ及びブタサーコウイルスに対する皮内混合ワクチン
CN110438029A (zh) * 2019-06-25 2019-11-12 成都天邦生物制品有限公司 一种猪肺炎支原体新型灭活方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5540568B2 (es) * 1972-10-05 1980-10-18
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4985243A (en) * 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
ES2112274T5 (es) * 1990-05-29 2006-03-01 Wyeth Holdings Corporation Vacuna contra la pneumonia en cerdos y metodo para la preparacion de la misma.
GB9108682D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Production of vaccines
JP5540568B2 (ja) 2008-07-31 2014-07-02 Ｊｆｅスチール株式会社 高炉炉体の建設および改修の方法

Also Published As

Publication number Publication date
EP0550477A1 (en) 1993-07-14
EP0550477B1 (en) 1997-04-23
CA2089552A1 (en) 1992-02-17
DK0550477T3 (da) 1997-10-27
AU8492391A (en) 1992-03-17
AU643829B2 (en) 1993-11-25
DE69125842D1 (de) 1997-05-28
JPH06503708A (ja) 1994-04-28
WO1992003157A1 (en) 1992-03-05
KR100286573B1 (ko) 2001-04-16
BR9106748A (pt) 1993-08-24
ATE151990T1 (de) 1997-05-15
CA2089552C (en) 2005-07-26
KR930701191A (ko) 1993-06-11
US5565205A (en) 1996-10-15
JP3040467B2 (ja) 2000-05-15
EP0550477A4 (en) 1993-12-01
GR3024214T3 (en) 1997-10-31
DE69125842T2 (de) 1998-05-28

Similar Documents

Publication Publication Date Title
ES2103827T3 (es) Vacuna muerta inactivada del mycoplasma hyopneumoniae y metodo de empleo de la misma.
ES2152421T3 (es) Vacunas de conjugados polisacarido neumococcico-neumolisina recombinante para la inmunizacion contra las infecciones neumococcicas.
SG46445A1 (en) Vaccines against cancer and infectious diseases
DE3787995D1 (de) Immunogen Konjugate.
CY1105389T1 (el) Hpv-e7 ως αγωγη εναντι του ιου θηλωματων ανθρωπου
KR890701758A (ko) 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신
ES2160601T3 (es) Vacunas de conjugado de polisacaridos de estreptococos del grupo b tipo ii y tipo v-proteina.
ES2158108T3 (es) Vacunacion in ovo contra la coccidiosis.
WO2003000204A3 (en) Multivalent mycoplasma bacterin
NL980007I1 (nl) Acellulair vaccin.
ES2058237T3 (es) Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
EP0839050A4 (es)
CA2187535A1 (en) Borrelia burgdorferi bacterin
DK0636030T3 (da) Pasteurella haemolytica type A-1-bacterin-toxoid-vaccine
PT1194450E (pt) Vacina inactivada contra a calicivirose felina
MX9300438A (es) Vacuna contra la estreptocinasa del streptococcus uberis.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 550477

Country of ref document: ES